Clinical trial
Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
NCT00132041 · American College of Radiology Imaging Network, Other · Completed
Key facts
| NCT number | NCT00132041 |
|---|---|
| Title | Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis |
| Official title | Multicenter Feasibility Study of Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in Cirrhotic Patients |
| Acronym | ACRIN-6673 |
| Lead sponsor | American College of Radiology Imaging Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Device |
| Interventions | radiofrequency ablation |
| Enrollment | 51 |
| Start date | Dec 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Nov 1, 2010 |
| First posted | Aug 19, 2005 |
| Last update posted | Sep 10, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: